The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Tempus AI, Inc. (TEM) filed a notice that officer Ryan M. Bartolucci plans to sell Class A common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The notice covers up to 6,175 shares, with an aggregate market value of $318,877, for potential sales on or after August 18, 2026 on NASDAQ.
The shares relate to equity awards granted as Restricted Stock Units and Performance Stock Units between 2022 and 2025. The company states these sales are mandated by its equity incentive plan to satisfy tax withholding obligations via sell-to-cover transactions and do not represent discretionary trades by Bartolucci.
Tempus AI, Inc. (TEM) received a notice that officer James William Rogers plans to sell 22,529 shares of Class A common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares stem from vested restricted stock units and performance stock units granted between April 2022 and August 2025.
The planned sale has an indicated aggregate market value of $1,163,397.56, compared with 175,390,967 Class A shares outstanding. Rogers previously sold 11,529 shares for $634,095 on June 25, 2026. The company states these sales are mandated sell-to-cover transactions to satisfy tax withholding obligations, not discretionary trades.
Tempus AI, Inc. (TEM) received a notice under Rule 144 that officer Thomas Edward Schoenherr plans to sell 9,232 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC on or about 08/18/2026. These shares relate to vested Restricted Stock Units and Performance Stock Units, and the company states the sales are mandated "sell to cover" transactions to satisfy tax withholding obligations rather than discretionary trades by Schoenherr.
Tempus AI, Inc. (TEM) is named as the issuer in a notice that officer James Rogers has arranged for the potential sale of company common stock under Rule 144. The notice lists 26,313 shares of common stock with an indicated value of $1,298,809.68, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.
The securities to be sold are tied to Restricted Stock Units, with a listed acquisition date of August 18, 2026. The notice also records prior Rule 10b5-1 plan sales for James Rogers over the past three months, including a sale of 11,529 shares of common stock on June 25, 2026, with an indicated value of $634,095.00.
Tempus AI, Inc. (TEM) received a notice that Andrew Polovin intends to sell 7,927 shares of Tempus AI common stock pursuant to Rule 144. The shares are held in an account at Morgan Stanley Smith Barney LLC Executive Financial Services and relate to Restricted Stock Units with an acquisition date of 08/18/2026 and a proposed sale date of 08/19/2026 on NASDAQ.
Tempus AI, Inc. (TEM) is the issuer of common stock that Thomas Schoenherr has notified may be sold under Rule 144. The notice covers up to 8,082 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $398,927.52 as of 08/19/2026. The shares relate to Performance Stock Units acquired from the issuer on 08/17/2026.
Tempus AI, Inc. (TEM) director Nadja West reported selling 3,000 shares of Class A Common Stock on August 14, 2026 at $53.90 per share in an open-market or private transaction. Following this sale, West directly holds 34,981 shares. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 15, 2026.
Tempus AI, Inc. executive Fukushima Ryan, CEO, Data, reported a bona fide gift of 62,239 shares of Class A Common Stock held indirectly through his spouse on 2026-08-12, for no additional consideration. Following the gift, indirect holdings by spouse were 61,706 shares, and Ryan also reported 603,558 shares held directly.
Tempus AI, Inc. officer Fukushima Ryan (CEO, Data) reported a sale of 20,000 shares of Class A Common Stock on August 7, 2026. The shares were sold at a weighted average price of $50.04 per share, in multiple trades between $50.00 and $50.15, and are held indirectly by the reporting person’s spouse under a Rule 10b5-1 trading plan adopted on March 12, 2026. Following this transaction, the spouse’s indirect holdings reported are 123,945 shares, and Fukushima Ryan also reports 603,558 shares held directly of the same class.